FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810210003> ?p ?o ?g. }

• W2810210003 endingPage "681" @default.
• W2810210003 startingPage "675" @default.
• W2810210003 abstract "Background: This study investigates the pharmacokinetics and pharmacodynamics of tacrolimus using the once-daily (OD) formulation in the early stage after living donor liver transplantation (LDLT) in comparison with those using the twice-daily (TD) formulation. Methods: Nine patients undergoing primary LDLT and treated with the OD tacrolimus formulation were included. The trough blood concentration (C 0 ) of tacrolimus was monitored every day for 3 weeks after LDLT. A time course study of the blood tacrolimus concentrations and calcineurin (CN) phosphatase activity in peripheral blood mononuclear cells was performed 3 weeks after LDLT. Pharmacokinetic and pharmacodynamic parameters were compared with previously reported data using the TD formulation. Results: The interindividual variability in the daily dose of tacrolimus was significantly larger in the OD formulation than in the TD formulation ( P < 0.001). In the time course study, the tacrolimus blood concentrations at 4, 8, and 12 hours after administration and the area under the concentration–time curve from 0 to 24 hours (AUC 0–24 ) in the OD group were significantly higher than in the TD group, although the C 0 was equivalent. In addition, the C 0 was not significantly correlated with the AUC 0–24 in the OD formulation. The apparent clearance and the pharmacodynamic parameters examined were not significantly different between the OD and TD groups. Conclusions: The C 0 monitoring of the OD formulation may not be optimal in patients at the early stage after LDLT because the C 0 was not correlated with the AUC 0–24 . If clinicians target the same C 0 using the OD and TD formulations, the exposure of tacrolimus can be higher in the OD formulation, and excessive immunosuppression should be noted. Particular attention should be paid to the patients in the early stage after LDLT in the use of the OD oral formulation of tacrolimus." @default.
• W2810210003 created "2018-07-10" @default.
• W2810210003 creator A5000976826 @default.
• W2810210003 creator A5002182436 @default.
• W2810210003 creator A5004410085 @default.
• W2810210003 creator A5013447444 @default.
• W2810210003 creator A5041300210 @default.
• W2810210003 creator A5056835579 @default.
• W2810210003 creator A5059944980 @default.
• W2810210003 creator A5061687607 @default.
• W2810210003 creator A5067304434 @default.
• W2810210003 creator A5068214663 @default.
• W2810210003 creator A5070223885 @default.
• W2810210003 creator A5072168969 @default.
• W2810210003 creator A5079724541 @default.
• W2810210003 date "2018-12-01" @default.
• W2810210003 modified "2023-10-18" @default.
• W2810210003 title "Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation" @default.
• W2810210003 cites W1488624658 @default.
• W2810210003 cites W1557067957 @default.
• W2810210003 cites W1592892624 @default.
• W2810210003 cites W1599829994 @default.
• W2810210003 cites W1944288770 @default.
• W2810210003 cites W1969355908 @default.
• W2810210003 cites W1981302647 @default.
• W2810210003 cites W1986643799 @default.
• W2810210003 cites W1989082515 @default.
• W2810210003 cites W1994924651 @default.
• W2810210003 cites W2016435159 @default.
• W2810210003 cites W2025752875 @default.
• W2810210003 cites W2028704154 @default.
• W2810210003 cites W2030448642 @default.
• W2810210003 cites W2059676586 @default.
• W2810210003 cites W2076798861 @default.
• W2810210003 cites W2088250393 @default.
• W2810210003 cites W2204234552 @default.
• W2810210003 cites W2278613351 @default.
• W2810210003 cites W2319410352 @default.
• W2810210003 cites W2472737495 @default.
• W2810210003 cites W4246823671 @default.
• W2810210003 doi "https://doi.org/10.1097/ftd.0000000000000551" @default.
• W2810210003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29965882" @default.
• W2810210003 hasPublicationYear "2018" @default.
• W2810210003 type Work @default.
• W2810210003 sameAs 2810210003 @default.
• W2810210003 citedByCount "7" @default.
• W2810210003 countsByYear W28102100032019 @default.
• W2810210003 countsByYear W28102100032020 @default.
• W2810210003 countsByYear W28102100032021 @default.
• W2810210003 crossrefType "journal-article" @default.
• W2810210003 hasAuthorship W2810210003A5000976826 @default.
• W2810210003 hasAuthorship W2810210003A5002182436 @default.
• W2810210003 hasAuthorship W2810210003A5004410085 @default.
• W2810210003 hasAuthorship W2810210003A5013447444 @default.
• W2810210003 hasAuthorship W2810210003A5041300210 @default.
• W2810210003 hasAuthorship W2810210003A5056835579 @default.
• W2810210003 hasAuthorship W2810210003A5059944980 @default.
• W2810210003 hasAuthorship W2810210003A5061687607 @default.
• W2810210003 hasAuthorship W2810210003A5067304434 @default.
• W2810210003 hasAuthorship W2810210003A5068214663 @default.
• W2810210003 hasAuthorship W2810210003A5070223885 @default.
• W2810210003 hasAuthorship W2810210003A5072168969 @default.
• W2810210003 hasAuthorship W2810210003A5079724541 @default.
• W2810210003 hasConcept C111113717 @default.
• W2810210003 hasConcept C112705442 @default.
• W2810210003 hasConcept C126322002 @default.
• W2810210003 hasConcept C126894567 @default.
• W2810210003 hasConcept C128057223 @default.
• W2810210003 hasConcept C1621761 @default.
• W2810210003 hasConcept C2779609443 @default.
• W2810210003 hasConcept C2780272996 @default.
• W2810210003 hasConcept C2909675724 @default.
• W2810210003 hasConcept C2910800852 @default.
• W2810210003 hasConcept C2911091166 @default.
• W2810210003 hasConcept C31785415 @default.
• W2810210003 hasConcept C71924100 @default.
• W2810210003 hasConcept C76318530 @default.
• W2810210003 hasConcept C98274493 @default.
• W2810210003 hasConceptScore W2810210003C111113717 @default.
• W2810210003 hasConceptScore W2810210003C112705442 @default.
• W2810210003 hasConceptScore W2810210003C126322002 @default.
• W2810210003 hasConceptScore W2810210003C126894567 @default.
• W2810210003 hasConceptScore W2810210003C128057223 @default.
• W2810210003 hasConceptScore W2810210003C1621761 @default.
• W2810210003 hasConceptScore W2810210003C2779609443 @default.
• W2810210003 hasConceptScore W2810210003C2780272996 @default.
• W2810210003 hasConceptScore W2810210003C2909675724 @default.
• W2810210003 hasConceptScore W2810210003C2910800852 @default.
• W2810210003 hasConceptScore W2810210003C2911091166 @default.
• W2810210003 hasConceptScore W2810210003C31785415 @default.
• W2810210003 hasConceptScore W2810210003C71924100 @default.
• W2810210003 hasConceptScore W2810210003C76318530 @default.
• W2810210003 hasConceptScore W2810210003C98274493 @default.
• W2810210003 hasIssue "6" @default.
• W2810210003 hasLocation W28102100031 @default.
• W2810210003 hasLocation W28102100032 @default.
• W2810210003 hasOpenAccess W2810210003 @default.
• W2810210003 hasPrimaryLocation W28102100031 @default.

• next